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ABSTRACTSbarrier which prevented patients from receiving surgery. Referral forms
were considered unwieldy. Appropriate BMI thresholds for surgery were
expressed as 46kg/m2, or 43kg/m2 with comorbidity, nearer to NICE
recommendations.
Conclusion: This identiﬁed a consensus for lower eligibility thresholds,
more funding, easier referral, outreach services to remote practices and
more information provided to primary care and patients. Surgeons require
direct referral and broadly support NICE guidelines.0578 PDS FOIL PLATE: ITS APPLICATION IN NASAL SURGERY
Louisa Ferguson, Joanne Rimmer, Hesham Saleh. Charing Cross Hospital,
London, UK
Aim: To evaluate functional and cosmetic outcomes after use of poly-
dioxanone foil in nasal and septal surgery.
Methods: Retrospective analysis of 60 patients in whom polydioxanone
foil was used over a two year period.
Results: Polydioxanone foil was used in a variety of different procedures,
including septoplasty, septorhinoplasty and closure of septal perforation.
49% of procedures were post-traumatic. Unperforated foil was used in 96%
of cases. There were no acute complications. Two patients required revi-
sion surgery (3.3%). The majority of patients achieved satisfactory func-
tional and cosmetic results.
Conclusion: PDS foil is safe to use in the nose, and has a range of appli-
cations in nasal reconstructive surgery.0580 FLUID AND ELECTROLYTE MANAGEMENT: UNDERGRADUATE
PREPARATION AND AWARENESS
Aswin Chari 1, John Findlay 2, Saurabh Singh 3, Joanna Cooke 1. 1University
of Oxford Medical School, Oxford, UK; 2Royal Berkshire Hospital, Reading, UK;
3University of Cambridge Medical School, Cambridge, UKAim: Perioperative ﬂuid management is routinely performed poorly by
juniordoctors, and is amajor causeof iatrogenicmorbidityandmortality. The
recent ASGBI GIFTASUP guidelines provide explicit surgical guidance,
particularly advocating routine use of balanced crystalloids. Poor knowledge
amongst junior doctors has been demonstrated. However, no studies have
assessedadequacyofundergraduatepreparation.This surveysought todoso.
Method: An 18 point questionnaire was distributed to all ﬁnal and
penultimate year medical students in Oxford and Cambridge. 100
responses were received.
Results: There were no differences between universities. Students had
received a mean 2.7 hours teaching on ﬂuid management and felt this
insufﬁcient. 16% were aware of the GIFTASUP guidelines. 86% knew
serum electrolyte concentrations, however, just 53%, 19% and 15% knew
the content of 0.9% saline, Hartmann's and gelofusin. 89% could calcu-
late 24 hour ﬂuid requirements, but only 50-60% could do so for elec-
trolytes. 0.9% saline was the preferred crystalloid for 45%; 37% thought
the choice of balanced/unbalanced crystalloid was irrelevant. Signiﬁ-
cant minorities could not identify relevant clinical considerations for
prescribing ﬂuid. Students were, however, reasonably conﬁdent in
prescribing ﬂuids.
Conclusions: Our survey suggests both the need and opportunity for
improvement in undergraduate preparation for surgical ﬂuid
management.0583 A COST EFFECTIVE ANALYSIS OF THE MANAGEMENT OF
EPISTAXIS
Jonathan Bird, Stuart Burrows, Warren Bennett, Venkat Reddy, Paul
Counter. Royal Devon and Exeter Hospitak, Exeter, Devon, UK
Introduction: Epistaxis is the most common ENT emergency and is often
treated by nasal packing. Traditionally, these patients have been admitted
at least overnight. We analyse a protocol for the outpatient management of
such patients.Methods: Retrospective audit of epistaxis admissions from April 2009 to
March 2010 to establish how many patients could potentially be managed
as outpatients (allowed home with anterior nasal packing in-situ attended
for subsequent outpatient management) based on modiﬁed Worthing
Hospital criteria.
Results: Of the 72 admissions, 16 were for observation, 56 had anterior
nasal packing. If the modiﬁedWorthing Hospital criteria had been applied,
35% of patients could have avoided admission.
Discussion: The cost of an overnight inpatient stay costs approximately
£315 per day. We conservatively estimate an £8000 saving per year in our
department with the introduction of the protocol.
With the increasing focus on healthcare costs we need to look at novel
ways of cost saving while still providing high quality care. Here we present
a simple and effective way of managing those patients who would tradi-
tionally be admitted.0587 PROTOCOL DRIVEN TREATMENT OF DVT: DOES IT PROVIDE THE
BEST RESULTS FOR PATIENTS WITH ILLIOFEMORAL DVT
Elizabeth Chandra, Patrick Coughlin, Marc Bailey, Barry McAree,
D.C. Berridge, D.J.A. Scott. Leeds Vascualr Institute, Leeds Teaching Hospitals
Trust, UK
Aims: Deep vein thrombosis (DVT) is common, causing signiﬁcant
morbidity and mortality. DVT is usually managed using validated protocol,
with treatment characteristically being delivered within a community
setting. Illiofemoral DVT increases the risk of developing the post-
thrombotic syndrome (PTS) some evidence suggests that these may be
best treated with catheter-directed thrombolysis (CDT) to reduce the risk
of PTS. We aimed to assess the effect of protocol / community delivered
care for DVT on a potential treatment option for illiofemoral DVT.
Methods: We identiﬁed 490 outpatients that underwent DVT directed
venous duplex between October 2009 and March 2010 within a large
teaching hospital trust. Suitability for CDT was determined using well
established criteria, based on national guidelines and international rand-
omised studies. Positive scans were investigated to establish if outpatient
treatment was given.
Results: Of the 490 outpatients, 93 (40 men) had evidence of DVT, of these
38 were illiofemoral. Twenty-two were suitable for CDT. None underwent
CDT; 12 were anticoagulated as outpatients, 9 were admitted for
anticoagulation and treatment of concurrent illness, 3 were not
anticoagulated.
Conclusions: A signiﬁcant proportion of patients deemed suitable are not
offered CDT. For this to occur it needs to be incorporated into current
treatment protocols.0589 SHOULD WARFARIN BE DISCONTINUED BEFORE ENDOVENOUS
LASER TREATMENT (EVLT)?
Abdul Hakeem, Stephen Hulligan, Iraj Zeynali, Frank Mason, David Jones.
Southport and Ormskirk District General Hospital, Southport, UK
Aim: EVLT has been shown to be a safe procedure. Since EVLT is a proce-
dure with no skin incisions, stopping warfarin prior to the procedure
seems unnecessary. Our aim was to determine if warfarin should be dis-
continued before EVLT.
Methods: Retrospective analysis of two consultant practice with respect
to warfarin therapy on EVLT patients between Jan 2004-Dec 2009. One
of the consultants routinely stopped warfarin atleast 3 days prior to
EVLT and other consultant continued warfarin. 810-nm diode laser was
used.
Results: There were 38 patients in Warfarin Withheld (WW) group and 30
inWarfarin Continued (WC) group. Themean agewas 64.7 (32-80) years in
WW and 61.9 (25-85) years in WC group. The average length of vein
treated and laser energy used was comparable in both the groups. There
was only one complication in WWgroup (n¼1, 2.6%), which was phlebitis.
There were more minor complications in WC group (n¼7, 23.3%)
(p¼0.0266, Fisher's exact test). These complications were haematoma
(n¼1), phlebitis (n¼4) and numbness (n¼2). The post-EVLT ablation rates
were similar in both the groups.
